LT - 3 Alfa-etinil, 3 beta-hidroksi-5 alfa-pregnan-20-oksimas, skirtas panaudoti CNS sutrikimų gydymui
EN - 3.ALPHA.-ETHYNYL, 3.BETA.-HYDROXY-5.ALPHA.-PREGNAN-20-OXIME FOR USE IN THE TREATMENT OF CNS DISORDERS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07J 41/00 |
(2006.01) |
|
|
A61K 31/57 |
(2006.01) |
|
|
A61P 25/28 |
(2006.01) |
|
|
A61P 25/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3245217 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
16704468.4 |
|
Date of filing the European patent application |
2016-01-11 |
| (97) |
Date of publication of the European application |
2017-11-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2019-10-02
|
| (46) |
Date of publication of the claims translation |
2019-12-27
|
PCT application
| (86) |
Number |
PCT/GB2016/050059 |
|
Date |
2016-01-11 |
PCT application publication
| (87) |
Number |
WO 2016/113549 |
|
Date |
2016-07-21 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
1500018 |
2015-01-12
|
SE |
Inventors
| (72) |
BÄCKSTRÖM, Torbjörn, SE
RAGAGNIN, Gianna, SE
|
Grantee
| (73) |
Umecrine Cognition AB,
Karolinska Institutet Science Park Fogdevreten 2, 171 65 Solna,
SE
|
Attorney or representative
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
Title
| (54) |
3 Alfa-etinil, 3 beta-hidroksi-5 alfa-pregnan-20-oksimas, skirtas panaudoti CNS sutrikimų gydymui |
| |
3.ALPHA.-ETHYNYL, 3.BETA.-HYDROXY-5.ALPHA.-PREGNAN-20-OXIME FOR USE IN THE TREATMENT OF CNS DISORDERS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-12-19 |
11 |
289.00
EUR
|
Next renewal fee
|
2027-01-11 |
